The Influence of Pioglitazone on NFkB Expression in CD40+ OrO Lymphocytes is Polymorphism-Dependent
| dc.contributor.author | Kaidashev, I. P. | |
| dc.contributor.author | Kutzenko, N. | |
| dc.contributor.author | Shlykova, O. | |
| dc.contributor.author | DuBuske, L. M. | |
| dc.contributor.author | Кайдашев, Ігор Петрович | |
| dc.contributor.author | Куценко, Н. | |
| dc.contributor.author | Шликова, Оксана Анатоліївна | |
| dc.date.accessioned | 2022-05-31T06:49:33Z | |
| dc.date.available | 2022-05-31T06:49:33Z | |
| dc.date.issued | 2009 | |
| dc.description.abstract | Expression of CD40 cells was unchanged in control or P cul tures. Expression of NFkB in CD40-positive cells significantly increased in all control cultures after 24 hours incubation. Addition of P to MNC in duced from 5 to 25% dose-dependent decrease in NFkB expression. The impact of P on CD40+ cells with the Prol2Ala polymorphism of PPAR- 7 was greatest on MNC from patients bearing the Alal2 allele. | uk_UA |
| dc.identifier.citation | The Influence of Pioglitazone on NFkB Expression in CD40+ OrO Lymphocytes is Polymorphism-Dependent : abstract sessions the 2009 AAAAI ANNUAL Meeting, March 13–17, Washington / I. P. Kaidashev, N. Kutzenko, O. Shlykova, L. M. DuBuske // The jornal of allergy and clinical immunology. – 2009. – Vol. 123, № 2. – P. 343. | uk_UA |
| dc.identifier.uri | https://repository.pdmu.edu.ua/handle/123456789/18478 | |
| dc.language.iso | en | uk_UA |
| dc.publisher | Washington | uk_UA |
| dc.title | The Influence of Pioglitazone on NFkB Expression in CD40+ OrO Lymphocytes is Polymorphism-Dependent | uk_UA |
| dc.type | Thesis | uk_UA |
Файли
Контейнер файлів
1 - 1 з 1
Ескіз недоступний
- Назва:
- Lymphocytes.pdf
- Розмір:
- 150.01 KB
- Формат:
- Adobe Portable Document Format
- Опис:
Ліцензійна угода
1 - 1 з 1
Ескіз недоступний
- Назва:
- license.txt
- Розмір:
- 4.3 KB
- Формат:
- Item-specific license agreed upon to submission
- Опис: